Synthesis, characterization and electrochemical behavior of oxo-bridged (arylimido)[tris(3,5-dimethylpyrazolyl)borato] molybdenum(V) complexes

Reaction of the oxo-molybdenum(V) precursor [MoTp*(O)Cl₂] [Tp* = hydrotris(3,5-dimethyl-1-pyrazolyl)borate] with H₂NC₆H₄R-4 (R = OEt; OPr) in refluxing toluene in the presence of Et₃N afforded the binuclear oxo-bridged oxo(arylimido) molybdenum(V) complexes [Tp*Mo(O)Cl](μ-O)[Tp*Mo(NC₆H₄OR-4)Cl]. Surprisingly, a similar reaction between [MoTp*(O)Cl₂] and C₆H₅NH₂ yielded the previously reported compound [{MoTp*(O)Cl}₂(μ-O)] as the only product. The new compounds were characterized by microanalytical data, mass spectrometry, IR and ¹H NMR spectroscopy. Cyclic voltammetric studies of the new compounds, of the previously reported compounds [Tp*Mo(O)Cl](μ-O)[Tp*Mo(NAr)Cl] (Ar = C₆H₄OMe-4, C₆H₄F-3, C₆H₄Cl-4, C₆H₄Br-4, and C₆H₄I-3), and of [{MoTp*(O)Cl}₂(μ-O)] revealed a reversible one-electron oxidation process that is little affected by the nature of the substituent on the aryl group, whereas it is greatly affected by replacement of the imido ligand with an oxo ligand. The [{MoTp*(O)Cl}₂(μ-O)] compound also shows a one-electron reduction process.     

Preparation, crystal structures and spectroscopic properties of novel [MCl3 − n(P)3 + n] (M = Co, Rh; n = 0, 1, 2 or 3) series of complexes containing tripodal tridentate phosphine, 1,1,1-tris(dimethylphosphinomethyl)ethane

Cobalt(III) and rhodium(III) complexes of the series of [M^IIICl_3 − n(P)_3 + n]ⁿ⁺ (M = Co or Rh; n = 0, 1, 2 or 3) have been prepared with the use of 1,1,1-tris(dimethylphosphinomethyl)ethane (tdmme) and mono- or didentate phosphines. The single-crystal X-ray analyses of both series of complexes revealed that the M-P and M-Cl bond lengths were dependent primarily on the strong trans influence of the phosphines, and secondarily on the steric congestion around the metal center resulting from the coordination of several phosphine groups. In fact, the M-P(tdmme) bonds became longer in the order of [MCl₃(tdmme)] < [MCl₂(tdmme)(PMe₃)]⁺ < [MCl(tdmme)(dmpe)]²⁺ (dmpe = 1,2-bis(dimethylphosphino)ethane) < [M(tdmme)₂]³⁺ for both Co^III and Rh^III series of complexes, while the M-Cl bond lengths were shortened in this order (except for [M(tdmme)₂]³⁺). Such a steric congestion around the metal center can also account for the structural and spectroscopic characteristics of the series of complexes, [MCl(tdmme)(dmpm, dmpe or dmpp)]²⁺ (dmpm = bis(dimethylphosphino)methane, dmpp = 1,3-bis(dimethylphosphino)propane). The X-ray analysis for [CoCl(tdmme)(dmpm or dmpe)](BF₄)₂ showed that all Co-P bonds in the dmpm complex were shorter by 0.03-0.04 Å than those in the dmpe complex. Furthermore, the first d-d transition energy of the Co^III complexes and the ¹J_Rh-P(tdmme) coupling constants observed for the Rh^III complexes indicated an unusual order in the coordination bond strengths of the didentate diphosphines, i.e., dmpm > dmpe > dmpp.     

A series of d transition metal coordination complexes: Structures and comparative study of surface electron behaviors (n = 9, 8, 7, 6, 5)

Ten transition metal coordination complexes [Cu₂(phen)(p-tpha)(μ-O)]_n1, [Cu(m-tpha)(imH)₂]_n2, [Ni(5-Haipa)₂(H₂O)₂]_n3, [Ni(phen)₂(H₂O)₂]·btc·[Ni(H₂O)₆]_0.5·9H₂O 4, [Co(2,5-pdc)(H₂O)₂]_n·nH₂O 5, [Co₂(2,5-pdc)₂(H₂O)₆]_n·2nH₂O 6, [Fe(2,5-Hpdc)₂(H₂O)₂]·H₂O 7, [Co(C₆H₄NO₂)₃]·H₂O 8, [Fe₂(μ₂-btec)(μ₂-H₂btec)(bipy)₂(H₂O)₂]_n9, [Mn(phen)(2,5-pdc)(H₂O)₂]·H₂O 10 (H₄btec = 1,2,4,5-benzenetetracarboxylic acid, phen = 1,10-phenanthroline, 2,5-H₂pdc = 2,5-pyridine-dicarboxylic acid, p-tpha = p-phthalic acid, m-tpha = m-phthalic acid, bipy = 2,2′-bipyridine, 5-H₂aipa = 5-aminoisophthalic acid, imH = imidazole, H₃btc = 1,3,5-benzenetricarboxylic acid) were synthesized through hydrothermal method. They were characterized by UV-Vis absorption spectra, single-crystal X-ray diffraction and surface photovoltage spectra (SPS). Structural analysis indicated that the complexes 1, 2, 3, 5, 6 and 9 were linked into infinite structures bridged by organic acid ligands. The other four complexes were molecular complexes and further connected to 2D or 3D structures by the hydrogen bonds. The SPS of complexes 1-10 indicate that there are positive response bands in the range of 300-800 nm showing different levels of photo-electric conversion properties. The intensity, position, shape and the number of the response bands in SPS are obviously different since the structure, species, valence, dⁿ electrons configuration and coordinated environment of the center metals are different. There are good relationships between SPS and UV-Vis spectra.     

Reactivity of [PdCl(μ-med)]2 with monodentate or bidentate ligands. Structure of the dinuclear complexes [Pd(μ-med)(PPh3)]2(BF4)2 and [Pd(μ-med)(bpy)]2(BF4)2. [Hmed=N-(2-mercaptoethyl)-3,5-dimethylpyrazole]

Treatment of the ligand N-(2-mercaptoethyl)-3,5-dimethylpyrazole with [Pd(CH₃COO)₂]₃ and reaction of [PdCl(μ-med)]₂ with pyridine (py) or triphenylphosphine (PPh₃) in the presence of AgBF₄ produced the following complexes: [Pd(CH₃COO)(μ-med)]₂, [Pd(μ-med)(py)]₂(BF₄)₂ and [Pd(μ-med)(PPh₃)]₂(BF₄)₂. Similar reactions carried out with 2,2^′-bipyridine (bpy) or 1,3-bis(diphenylphosphino)propane (dppp) produced [Pd(μ-med)(bpy)]_x(BF₄)_x (x=1 or 2) and [Pd(μ-med)(dppp)]_x(BF₄)_x (x=1 or 2). Treatment of [Pd(μ-med)(bpy)]_x(BF₄)_x with [PdCl₂(CH₃CN)₂] produced [Pd₃Cl₂(μ-med)₂(bpy)₂](BF₄)₂. Treatment of [Pd(μ-med)(dppp)]_x(BF₄)_x with [PdCl₂(CH₃CN)₂] produced a mixture of [Pd(μ-Cl)(dppp)]₂(BF₄)₂ and [Pd(μ-med)₂(dppp)]²⁺. X-ray crystal structures of [Pd(μ-med)(PPh₃)]₂(BF₄)₂ · 2CH₃CN and [Pd(μ-med)(bpy)]₂(BF₄)₂ · 0.5CH₃OH are presented.     

Synthesis, spectroscopy, structure and photophysical properties of dinaphthylmethylarsine complexes of palladium(II) and platinum(II)

Dinaphthylmethylarsine complexes of palladium(II) and platinum(II) with the formulae [MX₂L₂] (M = Pd, Pt; L = di(1-naphthyl)methylarsine = Nap₂AsMe and X = Cl, Br, I), [M₂Cl₂(μ-Cl)₂L₂], [PdCl(S₂CNEt₂)L], [Pd₂Cl₂(μ-OAc)₂L₂] and [MCl₂(PR₃)L] (PR₃ = PEt₃, PPr₃, PBu₃, PMePh₂) have been prepared. These complexes have been characterized by elemental analyses, IR, Raman, NMR (¹H, ¹³C, ³¹P) and UV-vis spectroscopy. The stereochemistry of the complexes has been deduced from the spectroscopic data. The crystal structures of trans-[PdCl₂(PEt₃)(Nap₂AsMe)] and of [Pd(S₂CNEt₂)₂], a follow-up product, were determined. The UV-vis spectra of [MX₂L₂] complexes show a red shift on going from X = Cl to X = I. The complexes [PdX₂L₂] and [PtX₂L₂] are strongly luminescent in fluid solution and in the solid at ambient temperature.     

Cyclometalated rhodium(III) and iridium(III) complexes containing amino acids as N,O-chelates

The synthesis of bis-cyclometalated aminocarboxylato complexes [M(α-aminocarboxylato)(ptpy)₂] (M = Rh, 3, 4, 5; M = Ir, 6, 7, 8), ptpy = 2-(p-tolyl)pyridinato; aminocarboxylato = glycinato, l-alaninato, l-prolinato) from [{M(μ-Cl)(ptpy)₂}₂] (M = Rh, 1; M = Ir, 2) is described. The molecular structure of [Ir(l-alaninato)(ptpy)₂] (7) was confirmed by a single-crystal X-ray diffraction study. Compound 7 crystallized from methanol-iso-hexane in the space group P2₁. For 7 the two diastereoisomers Δ_Ir, S_C and Λ_Ir, S_C were found crystallizing twice per unit. Absorption and emission spectra were recorded. The rhodium compounds are weak yellow-green and the iridium species strong green emitters.     

Synthesis, characterization and in vitro cytotoxicity studies of platinum(IV) complexes with thiouracil ligands

Reactions of [PtMe₃(bpy)(Me₂CO)][BF₄] (2) with the thionucleobases 2-thiouracil (s²Ura), 4-thiouracil (s⁴Ura) and 2,4-dithiouracil (s²s⁴Ura) resulted in the formation of complexes of the type [PtMe₃(bpy)(L-κS)][BF₄] (L = s²Ura, 3; s⁴Ura, 4; s²s⁴Ura, 5). The complexes were characterized by NMR spectroscopy (¹H, ¹³C, ¹⁹⁵Pt), IR spectroscopy as well as microanalyses. The coordination through the C4S groups (4, 5) was additionally confirmed by DFT calculations, where it was shown that these complexes [PtMe₃(bpy)(L-κS⁴)]⁺ (L = s⁴Ura, s²s⁴Ura) are about 5.8 (4b) and 3.3 kcal/mol (5b), respectively, more stable than the respective complexes, having thiouracil ligands bound through the C2X groups (X = O, 4a; S, 5a). For [PtMe₃(bpy)(s²Ura-κS²)][BF₄] (3) no preferred coordination mode could be assigned solely based on DFT calculations. Analysis of NMR spectra showed the κS² coordination. In vitro cytotoxic studies of complexes 3−5 on nine different cell lines (8505C, A253, FaDu, A431, A549, A2780, DLD-1, HCT-8, HT-29) revealed in most cases moderate activities. However, 3 and 5 showed significant activity towards A549 and A2780, respectively, possessing IC₅₀ values comparable to those of cisplatin. Cell cycle perturbations and trypan blue exclusion test on cancer cell line A431 using [PtMe₃(bpy)(s²s⁴Ura-κS⁴)][BF₄] (5) showed induction of apoptotic cell death. Furthermore, the reaction of [PtMe₃(OAc-κ²O,O′)(Me₂CO)] (6) with 4-thiouracil yielded the dinuclear complex [(PtMe₃)₂(μ-s⁴Ura_-H)₂] (7), which has been characterized by microanalysis, NMR (¹H, ¹³C, ¹⁹⁵Pt) and IR spectroscopy as well as ESI mass spectrometry. X-ray diffraction analysis of crystals yielded in an isolated case exhibited the presence of a hexanuclear thiouracilato platinum(IV) complex, possessing each three different kinds of methyl platinum(IV) moieties and 4-thiouracilato ligands. This exhibited the ability of 4-thiouracil platinum(IV) complexes to form multinuclear complexes.     

Stepwise syntheses, structure and spectroscopic studies of ruthenium complexes of 2,6-bis(benzimidazol-2-yl)pyridine with o-iminoquinone ancillary ligand

The ruthenium complexes [Ru^II(bbp)(L)(Cl)] (1), [Ru^II(bbp)(L)(H₂O)] (2) and [Ru^II(bbp)(L)(DMSO)] (3) {bbp = 2,6-bis(benzimidazol-2-yl)pyridine, L = o-iminoquinone} have been synthesized in a stepwise manner starting from [Ru^III(bbp)Cl₃]. The single crystal X-ray structures, except for the complex 2, have been determined. All the complexes were characterized by UV-Vis, FT-IR, ¹H NMR, Mass spectroscopic techniques and cyclic voltammetry. The Ru^III/Ru^II couple for complexes 1, 2, and 3 appears at 0.63, 0.49, 0.55 V, respectively versus SCE. It is observed that complex 2, on refluxing in acetonitrile, results into [Ru^II(bbp)(L)(CH₃CN)], 4 which has been prepared earlier in a different method. The structural, spectral and electrochemical properties of complexes 1, 2 and 3 were compared to those of earlier reported complex 4, [Ru^II(bbp)(L)(CH₃CN)].     

Selective synthesis of triangular cluster oxido-sulfidocomplexes of Mo and W: High yield preparations of [Mo3O2S2(H2O)9], [W3O2S2(H2O)9], [W2MoO2S2(H2O)9] and their derivatization

Reaction of [Mo₂O₂(μ-S)₂(H₂O)₆]²⁺ with Mo(CO)₆ or metallic Mo under hydrothermal conditions (140 °C, 4 M HCl) gives oxido-sulfido cluster aqua complex [Mo₃(μ₃-S)(μ-O)₂(μ-S)(H₂O)₉]⁴⁺ (1). Similarly, [W₃(μ₃-S)(μ-O)₂(μ-S)(H₂O)₉]⁴⁺ (2) is obtained from [W₂O₂(μ-S)₂(H₂O)₆]²⁺ and W(CO)₆. While reaction of [Mo₂O₂(μ-S)₂(H₂O)₆]²⁺ with W(CO)₆ mainly proceeds as simple reduction to give 1, [W₂O₂(μ-S)₂(H₂O)₆]²⁺ with Mo(CO)₆ produces new mixed-metal cluster [W₂Mo(μ₃-S)(μ-O)₂(μ-S)(H₂O)₉]⁴⁺ (3) as main product. From solutions of 1 in HCl supramolecular adduct with cucurbit[6]uril (CB[6]) {[Mo₃O₂S₂(H₂O)₆Cl₃]₂CB[6]}Cl₂⋅18H₂O (4) was isolated and structurally characterized. The aqua complexes were converted into acetylacetonates [M₃O₂S₂(acac)₃(py)₃]PF₆ (M₃ = Mo₃, W₃, W₂Mo; 5a-c), which were characterized by X-ray single crystal analysis, electrospray ionization mass spectrometry and ¹H NMR spectroscopy. Crystal structure of (H₅O₂)(Me₄N)₄[W₃(μ₃-S)(μ₂-S)(μ₂-O)₂(NCS)₉] (6), obtained from 2, is also reported.     

Diiron and diruthenium aminocarbyne complexes containing pseudohalides: stereochemistry and reactivity

Acetonitrile is easily displaced from [Fe₂{μ-CN(Me)(R)}(μ-CO)(CO)(MeCN)(Cp)₂][SO₃CF₃] (R = 2,6-Me₂C₆H₃ (Xyl) (1a); Me (1b)) upon stirring in THF at room temperature in the presence of [NBu₄][SCN]. The resulting complexes trans-[Fe₂{μ-CN(Me)(R)}(μ-CO)(CO)(NCS)(Cp)₂] (R = Xyl (trans-2a); Me (trans-2b)) are completely isomerised to cis-[Fe₂{μ-CN(Me)(R)}(μ-CO)(CO)(NCS)(Cp)₂] (R = Xyl (cis-2a); Me (cis-2b)) when heated at reflux temperature. Similarly, the complexes cis-[M₂{μ-CN(Me)(R)}(μ-CO)(CO)(NCO)(Cp)₂] (M = Fe, R = Me (4a); M = Ru, R = Xyl (4b); M = Ru, R = Me (4c)) and cis-[M₂{μ-CN(Me)(R)}(μ-CO)(CO)(N₃)(Cp)₂] (M = Fe, R = Xyl (5a); M = Fe, R = Me (5b); M = Ru, R = Xyl (5c)) can be obtained by heating at reflux temperature a THF solution of [M₂{μ-CN(Me)(R)}(μ-CO)(CO)(MeCN)(Cp)₂][SO₃CF₃] (M = Fe, R = Xyl (1a); M = Fe, Me (1b); M = Ru, R = Xyl (1c); M = Ru, R = Me (1d)) in the presence of NaNCO and NaN₃, respectively. The reactions of 5 with MeO₂CCCCO₂Me, HCCCO₂Me and (NC)(H)CC(H)(CN) afford the triazolato complexes [M₂{μ-CN(Me)(R)}(μ-CO)(CO){N₃C₂(CO₂Me)₂}(Cp)₂] (M = Fe, R = Xyl (6a); M = Fe, R = Me (6b); M = Ru, R = Xyl (6c)), [M₂{μ-CN(Me)(R)}(μ- CO)(CO){N₃C₂(H)(CO₂Me)}(Cp)₂] (M = Fe, R = Me (7a); M = Ru, R = Xyl (7b)) and [Fe₂{μ-CN(Me)(Xyl)}(μ-CO)(CO){N₃C₂(H)(CN)}(Cp)₂] (8), respectively. The asymmetrically substituted triazolato complexes 7-8 are obtained as mixtures of N(1) and N(2) bonded isomers, whereas 6 exists only in the N(2) form. Methylation of 6-8 results in the formation of the triazole complexes [Fe₂{μ-CN(Me)(Xyl)}(μ-CO)(CO){N₃(Me)C₂(CO₂Me)₂}(Cp)₂][CF₃SO₃] (9), [M₂{μ-CN(Me)(R)}(μ-CO)(CO){N₃(Me)C₂(H)(CO₂Me)}(Cp)₂][CF₃SO₃] (M = Fe, R = Me (10a); M = Ru, R = Xyl (10b)) and [Fe₂{μ-CN(Me)(Xyl)}(μ-CO)(CO){N₃(Me)C₂(H)(CN)}(Cp)₂][CF₃SO₃], 11. The crystal structures of trans-2b, 4b · CH₂Cl₂, 5a, 6b · 0.5CH₂Cl₂ and 8 · CH₂Cl₂ have been determined.     

Novel halogen-bridged bisphosphine nickel(II) complexes

Reaction of [NiCl₂(dtbpe)] (dtbpe = 1,2-bis(di-tert-butylphosphino)ethane) with one equivalent of NaBAr^F₄ (BAr^F₄ = tetrakis[3,5-bis(trifluoromethyl)phenyl]borate) gives the dinuclear chloro-bridged nickel complex [Ni₂(μ-Cl)₂(dtbpe)₂](BAr^F₄)₂ (1). [Ni(solv)₆](BF₄)₂ reacts with dtbpe to give, depending on the solvent, the fluoro-bridged complex [Ni₂(μ-F)₂(dtbpe)₂](BF₄)₂ (2) (solv = THF) or the mononuclear chelate complex [Ni(MeCN)₂(dtbpe)](BF₄)₂ (3) (solv = MeCN). In 1-3, nickel cations are coordinated in a square-planar fashion according to X-ray crystallography. No Ni-Ni interaction was observed in dinuclear halogen-bridged complexes 1 and 2.     

Synthesis, characterization, crystal structures, and photophysical properties of a series of room-temperature phosphorescent copper(I) complexes with oxadiazole-derived diimine ligand

In this paper, we report four phosphorescent Cu(I) complexes of [Cu(OP)(PPh₃)₂]BF₄, [Cu(Me-OP)(PPh₃)₂]BF₄, [Cu(OP)(POP)]BF₄, and [Cu(Me-OP)(POP)]BF₄ with oxadiazole-derived diimine ligands, where OP = 2-(5-phenyl-[1,3,4]oxadiazol-2-yl)-pyridine, Me-OP = 2-(5-p-tolyl-[1,3,4]oxadiazol-2-yl)-pyridine, POP = bis(2-(diphenylphosphanyl)phenyl) ether, and PPh₃ = triphenylphosphane, including their synthesis, crystal structures, photophysical properties, and electronic nature. The Cu(I) center has a distorted tetrahedral geometry within the Cu(I) complexes. Theoretical calculation reveals that all emissions originate from triplet metal-to-ligand-charge-transfer excited state. It is found that the inter-molecular sandwich structure triggered by inter- and intra-molecular pi-stacking within solid state Cu(I) complexes is highly effective on restricting the geometric relaxation that occurs in excited states, and thus greatly enhances the photoluminescence (PL) performances, including PL quantum yield improvement, PL decay lifetime increase, and emission blue shift.     

Calix[4]arene supported group 5 imido complexes

The reaction of imidoyl chlorides [V(NR)Cl₃] (R = Ph 1, Tol 2, tBu 3) and calix[4]arene methyl ether H₃Mecalix unexpectedly leads to the formation of the structurally characterized vanadium (IV) complex [VCl(Mecalix)] (4). Calix[4]arene methyl ether stabilized imido complexes of the type [V(NR)(Mecalix)] (R = Ph 7, Tol 8, tBu 9) were afforded from the reaction of [V(NR)Cl₃] (R = Ph 1, Tol 2, tBu 3) and the tris(lithium) or tris(sodium) salt of the calix[4]arene ether. The lithium salt [{Li₃(Mecalix)}₂] (5) is a dimer in the solid state, in which two monomeric trianions are bridged by lithium cations. Imido complexes [M(NR)(Mecalix)] (M = Nb: R = tBu, 12, R = Tol 13, R = Mes 14, R = Dipp 15; M = Ta: R = tBu 16, R = Tol 17) (Tol = 4-C₆H₄Me, Mes = 2,6-C₆H₃Me₂; Dipp = 2,6-C₆H₃iPr₂) have been prepared from structurally characterized [NbCl₂(Mecalix)] (10) and previously known [TaCl₂(Mecalix)] (11) via reaction with two equivalents of the appropriately metallated (Li, K) primary amine. The molecular structures of 13 and 15 confirm the mononuclear nature of these complexes.     

Synthesis and characterization of platinum(IV) complexes with N,S and S,S heterocyclic ligands

The reactions of [PtMe₃(OAc)(bpy)] (4) with the N,S and S,S containing heterocycles, pyrimidine-2-thione (pymtH), pyridine-2-thione (pytH), thiazoline-2-thione (tztH) and thiophene-2-thiol (tptH), resulted in the formation of the monomeric complexes [PtMe₃(-κS)(bpy)] ( = pymt, 5; pyt, 6; tzt, 7; tpt, 8), where the heterocyclic ligand is coordinated via the exocyclic sulfur atom. In contrast, in the reactions of [PtMe₃(OAc)(Me₂CO)_x] (3, x = 1 or 2) with pymtH, pytH, tztH and tptH dimeric complexes [{PtMe₃(μ-)}₂] (μ- = pymt, 9; pyt, 10; tzt, 11) and the tetrameric complex [{PtMe₃(μ₃-tpt-κS)}₄] (12), respectively, were formed. The complexes were characterized by microanalyses, ¹H and ¹³C NMR spectroscopy and negative ESI-MS (12) measurements. Single-crystal X-ray diffraction analysis of [PtMe₃(pymt-κS)(bpy)] (5) exhibited a conformation where the pymt ligand lies nearly perpendicular to the complex plane above the bpy ligand that was also confirmed by quantum chemical calculations on the DFT level of theory.     

Effect of copper-substitution on the structure and nuclearity of Cu(II)-pyrazolates: from trinuclear to tetra-, hexa- and polynuclear complexes

The influence of terminal ligands on the structure and nuclearity of copper(II)-pyrazolates has been investigated. Exchange of the chloride ligands of [Cu₃(μ₃-X)(μ-pz)₃Cl₃]ⁿ⁻ (X=O, OH; n=2, 1) or [Cu₃(μ₃-Cl)₂(μ-pz)₃Cl₃]²⁻ complexes for cyanate, acetate or bromide ligands maintains the integrity of the triangular species: PPN[Cu₃(μ₃-OH)(μ-pz)₃(NCO)₃], PPN[Cu₃(μ₃-OH)(μ-pz)₃(O₂CCH₃)₃(H₂O)] · H₂O, Bu₄N[Cu₃(μ₃-OH)(μ-pz)₃(O₂CCH₃)₃] · 3H₂O and (Bu₄N)₂[Cu₃(μ₃-Br)₂(μ-pz)₃Br₃] have been prepared and characterized by spectroscopic and X-ray diffraction techniques, respectively. In contrast, tetranuclear complexes (Bu₄N)₂[Cu₄(μ₃-OH)₂(μ-4-X-pz)₂(μ-O₂CPh)₂(O₂CPh)₄] (X=H, Cl, Br, NO₂) and the hexanuclear complex (Bu₄N)₂[Cu₆(μ₃-O)(μ₃-OH)(μ-4-NO₂-pz)₆(μ-O₂CPh)₃(O₂CPh)₂(H₂O)] · (CH₂Cl₂)_0.5 have been obtained on substitution for benzoate ligands. An attempt to partially substitute the chlorides for tert-butoxide ligands, also provided a tetranuclear complex, (Bu₄N)₂[Cu₄(μ-OH)₂(μ-pz)₄Cl₄], without incorporation of the incoming ligand. Similarly, removal of all chloride ions in the absence of an appropriate substituting ligand leads to higher nuclearity metallacycles [Cu(μ-OH)(μ-pz)]_n (n=6, 8, 9, 12, 14).     

Effect of pyrazole-substitution on the structure and nuclearity of Cu(II)-pyrazolato complexes

Trinuclear Cu(II)-pyrazolates of the general formula (Bu₄N)₂[Cu₃(μ₃-Cl)₂(μ-4-R-pz)₃Cl₃] (pz=pyrazolato anion, R=Cl, Br, I, Me), 1-4, have been prepared and characterized by X-ray diffraction and/or ¹H NMR, IR, UV-Vis spectroscopy and elemental analysis. Their structure and spectroscopic properties match the ones of the parent unsubstituted complex (Bu₄N)₂[Cu₃(μ₃-Cl)₂(μ-pz)₃Cl₃], indicating that 4-substitution of the pyrazole ligands with halogen or methyl groups does not induce structural variation. In contrast, dinuclear complexes (Bu₄N)₄[Cu₂(μ-3-Me-pz)₂Cl₄]Cl₂ · 4H₂O, Cu₂(μ-Cl)(μ-3,5-Me₂-pz)(3,5-Me₂-pzH)₄Cl₂, Cu₂(μ-Cl)(μ-OH)(3-Me-5-Ph-pzH)₄Cl₂ · 3-Me-5-Ph-pzH and Cu₂(μ-Cl)₂(3,5-Ph₂-pzH)₄Cl₂, 5-8, have been prepared with 3- and 3,5-substituted pyrazoles by the same or similar synthetic protocols.     

Novel dioxomolybdenum(VI) and oxomolybdenum(V) complexes with pyridoxal thiosemicarbazone ligands: Synthesis and structural characterisation

New molybdenum complexes were prepared by the reaction of [Mo^VIO₂(acac)₂] or (NH₄)₂[Mo^VOCl₅] with different N-substituted pyridoxal thiosemicarbazone ligands (H₂L¹ = pyridoxal 4-phenylthiosemicarbazone; H₂L² = pyridoxal 4-methylthiosemicarbazone, H₂L³ = pyridoxal thiosemicarbazone). The investigation of monomeric [MoO₂L¹(CH₃OH)] or polymeric [MoO₂L^1-3] molybdenum(VI) complexes revealed that molybdenum is coordinated with a tridentate doubly-deprotonated ligand. In the oxomolybdenum(V) complexes [MoOCl₂(HL^1-3)] the pyridoxal thiosemicarbazonato ligands are tridentate mono-deprotonated. Crystal and molecular structures of molybdenum(VI) [MoO₂L¹(CH₃OH)]·CH₃OH, and molybdenum(V) complexes [MoOCl₂(HL¹)]·C₂H₅OH, as well as of the pyridoxal thiosemicarbazone ligand methanol solvate H₂L³·MeOH, were determined by the single crystal X-ray diffraction method.     

Methimazole complexes of platinum(II): Synthesis, characterization and redox behavior

A variety of platinum(II) complexes of methimazole (2-mercapto-1-methylimidazole; HImS = neutral form and ImS = thiolate form), coordinated in both thione and thiolate forms, have been isolated by reacting methimazole with [PtCl(terpy)]Cl (terpy = 2,2′:6′,2″ terpyridine), [PtCl₂(bipy)] (bipy = bipyridine), [PtCl₂(o-phen)] (o-phen = o-phenanthroline), [PtCl₂(CH₃CN)₂] and [PtCl₂(COD)] (COD = 1,5-cyclooctadiene). These complexes were characterized by electronic absorption, IR and NMR (¹H, ¹³C, ¹⁹⁵Pt) spectroscopies. Molecular structure of [Pt(bipy)(HImS)₂]Cl₂·3H₂O (3a·3H₂O) has been established by single crystal X-ray crystallography. Platinum thiolate complex, [Pt(ImS)₂(HImS)₂] (5), could be obtained by treatment of [Pt(HImS)₄]Cl₂ with sodium methoxide in methanol. The solution of 5 in organic solvents yielded bi- and tri-nuclear platinum complexes. The effect of diimine ligands on oxidation of methimazole moiety in the complexes has been studied by electrochemical oxidation and pulse radiolytic oxidation employing specific one-electron oxidant, radical.     

Synthesis of a novel pyridine-diamino bridged diphosphine ligand and its macrocyclic metal complexes

A novel long chain diphosphine ligand with a pyridine-diamino bridge, 2,6-bis(N-benzyl-N-diphenylphosphinomethylamino)pyridine (PNP1), was prepared conveniently using the Mannich reaction of HPPh₂ with paraformaldehyde and 2,6-bis(N-benzylamino)pyridine in high yield. Reactions of the ligand with metal complexes, M(COD)Cl₂ (M = Pd, Pt), M(CH₃CN)₄ClO₄ (M = Cu, Ag) and M(CO)₆ (M = Mo, W) afforded the corresponding 10-numbered monometallic macrocyclic complexes with an uncoordinated pyridyl bridge. The monometallic chelate PdCl₂(PNP1) continued to react with Ag⁺ or Cu⁺ giving the μ-Cl bridged bicyclic metallic complex (μ-Cl)₂[PdCl(PNP1)]₂. The diphenylphosphine group coordinated with metal ion in cis-form in all the 10-numbered macrocyclic metal complexes. Ligand PNP1 and another known analogous 2,6-bis(N-diphenylphosphinoamino)pyridine (PNP2) reacted with Au(SMe₂)Cl giving the corresponding bimetallic Au₂Cl₂(PNP1) and Au₂Cl₂(PNP2), respectively. The latter bimetallic complexes continued to react with Ag⁺ and diphosphine ligand to give the corresponding bimetallic macrocyclic complexes Au₂(ligand)₂(ClO₄)₂. All the complexes were characterized and the structures of some complexes were confirmed by X-ray single crystallography determination.     

Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands

The first [Pd(Lⁿ)₂(ox)] xH₂O oxalato(ox) complexes involving 2-chloro-N6-(benzyl)-9-isopropyladenine (L¹; complex 1), 2-chloro-N6-(4-methoxybenzyl)-9-isopropyladenine (L²; 2), 2-chloro-N6-(2,3-dimethoxybenzyl)-9-isopropyladenine (L³; 3), 2-chloro-N6-(2,4-dimethoxybenzyl)-9-isopropyladenine (L⁴; 4), and 2-chloro-N6-(4-methylbenzyl)-9-isopropyladenine (L⁵; 5) have been synthesized by the reactions of potassium bis(oxalato)palladate(II) dihydrate, [K₂Pd(ox)₂]·2H₂O, with the mentioned organic compounds (H₂ox = oxalic acid; x = 0 for 1-3 and 5 or 2 for 4). Elemental analyses (C, H, N), FTIR, Raman and NMR (¹H, ¹³C, ¹⁵N) spectroscopies, conductivity measurements and thermal studies (thermogravimetric and differential thermal analyses, TG/DTA) have been used to characterize the prepared complexes. The molecular structures of [Pd(L²)₂(ox)] (2) and [Pd(L⁵)₂(ox)]·L⁵·Me₂CO (5·L⁵·Me₂CO) have been determined by a single crystal X-ray analysis. The geometry of these complexes is slightly distorted square-planar with two appropriate Lⁿ (n = 2 or 5) molecules mutually arranged in the head-to-head (2) or head-to-tail (5) orientation. The Lⁿ ligands are coordinated to the central Pd(II) ion via the N7 atoms. The same conclusions regarding the binding properties of L¹-L⁵ ligands can be made based on multinuclear NMR spectra. In vitro cytotoxicity of the complexes 1-5 has been evaluated against human chronic myelogenous leukaemia (K562) and human breast adenocarcinoma (MCF7) cancer cell lines. Significant cytotoxicity has been determined for the complexes 3 (IC₅₀ = 6.2 μM) and 5 (IC₅₀ = 6.8 μM) on the MCF7 cell line, which is even better than that found for the well-known and widely-used platinum-bearing antineoplastic drugs, i.e. oxaliplatin and cisplatin.